Supplementary Table S3 from Circulating Exosomal PD-L1 at Initial Diagnosis Predicts Outcome and Survival of Patients with Osteosarcoma

Benzer Materyaller

• Supplementary Figure S1 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
  Yazar:: Javier Pascual (15018176)
  Baskı/Yayın Bilgisi: (2025)
• Supplementary Figure S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
  Yazar:: Javier Pascual (15018176)
  Baskı/Yayın Bilgisi: (2025)
• Supplementary Figure S3 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
  Yazar:: Javier Pascual (15018176)
  Baskı/Yayın Bilgisi: (2025)
• Supplementary Figure S4 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
  Yazar:: Javier Pascual (15018176)
  Baskı/Yayın Bilgisi: (2025)
• Supplementary Figure S5 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
  Yazar:: Javier Pascual (15018176)
  Baskı/Yayın Bilgisi: (2025)